NYU Accuses Resmed of Patent Breach Over Popular Sleep Apnea Product

According to NYU’s complaint filed in the Southern District of New York, the university sent Resmed chief executive Michael Farrell a letter in early June demanding the health group disable key features of its device within 24 hours. The company did not accede to NYU’s request.

Resmed sells a range of products and masks that help treat sleep apnoea and other conditions. This includes its hugely successful machine to treat sleep apnoea, the AirSense 10 — the device at the center of the NYU lawsuit.

The university is seeking unpaid royalties, interest and costs. The quantum of NYU’s claim is not currently disclosed.

Read the article here.

Source: Sydney Morning Herald

Be the first to comment

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.